CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 46 enrolled
Drug / intervention
Clonazepam +2 moredrug
Likely dose
Not stated in record
Key inclusion· 1
  • ✓Confirmed diagnosis of panic disorder
Key exclusion· 4
  • ✕History of bipolar disorder, schizophrenia, psychosis, or delusional disorders
  • ✕Post-traumatic stress disorder diagnosis within 6 months prior to study entry
  • ✕Current use of psychotropic medications
  • ✕Current use of cognitive behavioral therapy

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00118417
NCT00118417Phase 3Completed
CompareCT.gov

Treatment Refractory Panic Disorder

Massachusetts General Hospital·interventional·Posted Jul 11, 2005·Updated Jun 11, 2014

In Brief

A Phase 3 clinical trial evaluating Clonazepam, Sertraline, and 1 other intervention for Panic Disorder. Completed, enrolled 46 participants across 1 site.

Detailed Summary

This study will determine the effectiveness of different treatments for panic disorder symptoms in individuals who still have symptoms after initial treatment with medication.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPanic Disorder
CountriesUnited States
CollaboratorsNational Institute of Mental Health (NIMH)

Timeline

Phase 3CompletedFinished
19992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 11, 2005
Enrollment StartMar 1, 1999
Primary CompletionOct 1, 2007
TodayJul 2, 2026
Enrollment to primary: 8.6 yearsPosted 21.0 years ago

Interventions

Clonazepamdrug

Participants will receive clonazepam.

Sertralinedrug

Participants will receive sertraline.

Cognitive behavioral therapybehavioral

Participants will receive cognitive behavioral therapy